Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
19 July, 2018 20:52 IST
Suven Life Sciences secures 2 overseas product patents
Source: IRIS | 17 May, 2018, 11.03AM
Comments  |  Post Comment

Suven Life Sciences announces today that the grant of two product patents from Australia and one product patent from Singapore corresponding to the New Chemical Entities (NCEs) for the treatment of disorders associated with Neurodegenerative diseases and these Patents are valid through 2034.

The granted claims of the patents include the class of selective H3 Inverse agonists and 5HT6 compounds respectively and are being developed as therapeutic agents for major depressive disorders and for the treatment of cognitive impairment associated with neurodegenerative disorders like Alzheimer's disease, Attention deficient hyperactivity disorder (ADHD), Huntington's disease, Narcolepsy, Parkinson and Schizophrenia respectively.

''We are very pleased by the grant of these patents to Suven for our pipeline of molecules in CNS arena that are being developed for cognitive disorders with high unmet medical need with huge market potential globally,'' says Venkat Jasti, CEO of Suven.

Shares of the company declined Rs 3.05, or 1.59%, to trade at Rs 188.65. The total volume of shares traded was 28,852 at the BSE (10.49 a.m., Thursday).





Suven Life Sciences Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Company Update
Yes Bank partners with 10 smart cities to tackle development challenges - 19-Jul-2018 17:36
Govt to infuse capital worth Rs 17.9 bn in Allahabad Bank - 19-Jul-2018 16:17
Trigyn Technologies wins contract from U.S. Army Picatinny Arsenal - 19-Jul-2018 16:11
Kotak Mahindra Bank quarterly net climbs 12.3% to Rs 10.25 bn - 19-Jul-2018 15:58
Bajaj Finance quarterly profit surges 83% - 19-Jul-2018 15:32
Tata Motors bags order to supply electric vehicles to Cognizant - 19-Jul-2018 13:19
Infosys Foundation signs accord with Bangalore Metro - 19-Jul-2018 11:49
Lupin receives tentative USFDA approval for generic Tadalafil tablets - 19-Jul-2018 11:34
Zydus Cadila gets USFDA's final nod for Piroxicam capsules - 19-Jul-2018 10:26
MCX takes preventive measures against technical glitches - 19-Jul-2018 10:19
Tata Power launches electric vehicle charging stations in Hyderabad - 18-Jul-2018 15:45
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer